Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Gwendolyn Lynch, MD

216.445.2816

Gwendolyn Lynch, MD
Department: Cerebrovascular Center
Location: Cleveland Clinic Main Campus
Mail Code S80
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.445.2816
WorkFax:216.636.2061
Gwendolyn Lynch, MD
Department: Neurology
Location: Cleveland Clinic Main Campus
Mail Code S80
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.445.2816
WorkFax:216.636.2061
Gwendolyn Lynch, MD
Department: Neurological Surgery
Location: Cleveland Clinic Main Campus
Mail Code S80
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:330.287.4500
WorkFax:216.636.2061
Surgeon:
No
Treats:
Both Adults and Children & Adolescents

Biographical Sketch

Gwendolyn Lynch, MD, is a Staff Physician at Cleveland Clinic and is board-certified in neurology, neurocritical care, and vascular neurology/stroke.

As an attending physician in the neuro-intensive care unit, she is responsible for the management of patients with critical vascular disease as well as other neurocritical illnesses. 

Dr. Lynch's research interests include stroke epidemiology and risk-factor modification, neurocritical care, impact of renal disease on stroke outcome, and neurocritical care quality measures.

Education & Fellowships

Fellowship - University of Virginia Health Sciences Center
Neurocritical Care
VA USA
1996
Fellowship - University of Virginia Health Sciences Center
Stroke-Neurology
VA USA
1995
Residency - Yale-New Haven Hospital
Neurology
New Haven, CT USA
1994
Residency - The Ohio State University Hospitals
Neurology
Columbus, OH USA
1992
Internship - The Ohio State University Hospitals
Internal Medicine
Columbus, OH USA
1991
Medical School - The Ohio State University College of Medicine and Public Health
Columbus, OH USA
1990

Certifications

  • Neurology
  • Neurology- Vascular Neurology
  • United Council for Neurologic Subspecialties- Neurocritical Care

Specialty Interests

carotid artery stenosis, cerebrovascular disease, cerebrovascular neurology, hemorrhagic stroke, intracranial stenosis, ischemic stroke, neurocritical care, neurocritical care quality measures, neurologic intensive care, neurological critical care, neurological intensive care, neurosurgical intensive care, secondary stroke prevention, stroke, stroke epidemiology and risk factor modification, stroke outcomes,

Memberships

  • American Stroke Association/American Heart Association
  • American Academy of Neurology
  • Neurocritical Care Society
  • Society of Critical Care Medicine

Treatment & Services

  • Cerebrovascular Neurology
  • Clinical Evaluation, Diagnosis And Treatment
  • Management of Intracranial Hypertension
  • Neurocritical Care
  • Neurological Intensive Care
  • Neurosurgical Intensive Care
  • Stroke Epidemiology
  • Thrombolysis
  • Tracheal Intubation
  • Ventilator Management

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/24/2014, Dr. Lynch has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English